# Bridgeline Digital, Inc.: financial statements, quarterly

BLIN · Nasdaq · CIK 1378590 · [Technology](/sectors/technology.md) · fiscal year ends Sep 30

Pages: [Overview](/companies/blin.md) · [Financials](/companies/blin/financials.md) · [Filings](/companies/blin/filings.md) · [Insiders](/companies/blin/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/blin/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [3,798 d](/filings/0001437749-24-038328.md) | [3,755](/filings/0001437749-25-003789.md) | [3,804](/filings/0001437749-25-017251.md) | [3,936](/filings/0001437749-25-026998.md) | [3,863 d](/filings/0001437749-25-038337.md) | [3,791](/filings/0001437749-26-003978.md) | [3,875](/filings/0001437749-26-017162.md) | [3,846](/filings/0001437749-26-027732.md) | [3,871 d](/filings/0001437749-25-038337.md) | [3,913](/filings/0001437749-26-003978.md) | [3,917](/filings/0001437749-26-017162.md) | [3,922](/filings/0001437749-26-027732.md) |
| Cost of revenue | $k | [1,206 d](/filings/0001437749-24-038328.md) | [1,203](/filings/0001437749-25-003789.md) | [1,280](/filings/0001437749-25-017251.md) | [1,230](/filings/0001437749-25-026998.md) | [1,211 d](/filings/0001437749-25-038337.md) | [1,256](/filings/0001437749-26-003978.md) | [1,259](/filings/0001437749-26-017162.md) | [1,298](/filings/0001437749-26-027732.md) | [1,329 d](/filings/0001437749-25-038337.md) | [1,325](/filings/0001437749-26-003978.md) | [1,397](/filings/0001437749-26-017162.md) | [1,393](/filings/0001437749-26-027732.md) |
| Gross profit | $k | [2,592 d](/filings/0001437749-24-038328.md) | [2,552](/filings/0001437749-25-003789.md) | [2,524](/filings/0001437749-25-017251.md) | [2,706](/filings/0001437749-25-026998.md) | [2,652 d](/filings/0001437749-25-038337.md) | [2,535](/filings/0001437749-26-003978.md) | [2,616](/filings/0001437749-26-017162.md) | [2,548](/filings/0001437749-26-027732.md) | [2,542 d](/filings/0001437749-25-038337.md) | [2,588](/filings/0001437749-26-003978.md) | [2,520](/filings/0001437749-26-017162.md) | [2,529](/filings/0001437749-26-027732.md) |
| Research and development | $k | [1,070 d](/filings/0001437749-24-038328.md) | [1,093](/filings/0001437749-25-003789.md) | [1,037](/filings/0001437749-25-017251.md) | [1,008](/filings/0001437749-25-026998.md) | [1,022 d](/filings/0001437749-25-038337.md) | [1,073](/filings/0001437749-26-003978.md) | [1,110](/filings/0001437749-26-017162.md) | [961](/filings/0001437749-26-027732.md) | [880 d](/filings/0001437749-25-038337.md) | [792](/filings/0001437749-26-003978.md) | [873](/filings/0001437749-26-017162.md) | [936](/filings/0001437749-26-027732.md) |
| Operating income | $k | [(8,226) d](/filings/0001437749-24-038328.md) | [(635)](/filings/0001437749-25-003789.md) | [(519)](/filings/0001437749-25-017251.md) | [(383)](/filings/0001437749-25-026998.md) | [(482) d](/filings/0001437749-25-038337.md) | [(511)](/filings/0001437749-26-003978.md) | [(745)](/filings/0001437749-26-017162.md) | [(689)](/filings/0001437749-26-027732.md) | [(482) d](/filings/0001437749-25-038337.md) | [(171)](/filings/0001437749-26-003978.md) | [(426)](/filings/0001437749-26-017162.md) | [(470)](/filings/0001437749-26-027732.md) |
| Income tax | $k | [(119) d](/filings/0001437749-24-038328.md) | [5.0](/filings/0001437749-25-003789.md) | [5.0](/filings/0001437749-25-017251.md) | [5.0](/filings/0001437749-25-026998.md) | [(58.0) d](/filings/0001437749-25-038337.md) | [5.0](/filings/0001437749-26-003978.md) | [5.0](/filings/0001437749-26-017162.md) | [5.0](/filings/0001437749-26-027732.md) | [(54.0) d](/filings/0001437749-25-038337.md) | [5.0](/filings/0001437749-26-003978.md) | [5.0](/filings/0001437749-26-017162.md) | [5.0](/filings/0001437749-26-027732.md) |
| Net income | $k | [(8,063) d](/filings/0001437749-24-038328.md) | [(622)](/filings/0001437749-25-026998.md) | [(602)](/filings/0001437749-25-026998.md) | [(305)](/filings/0001437749-25-026998.md) | [(432) d](/filings/0001437749-25-038337.md) | [(634)](/filings/0001437749-26-027732.md) | [(730)](/filings/0001437749-26-027732.md) | [(789)](/filings/0001437749-26-027732.md) | [(365) d](/filings/0001437749-25-038337.md) | [(86.0)](/filings/0001437749-26-027732.md) | [(432)](/filings/0001437749-26-027732.md) | [(468)](/filings/0001437749-26-027732.md) |
| Diluted EPS | $ per share | not reported | [(0.06)](/filings/0001437749-25-003789.md) | [(0.06)](/filings/0001437749-25-017251.md) | [(0.03)](/filings/0001437749-25-026998.md) | not reported | [(0.06)](/filings/0001437749-26-003978.md) | [(0.10)](/filings/0001437749-26-017162.md) | [(0.07)](/filings/0001437749-26-027732.md) | not reported | [(0.01)](/filings/0001437749-26-003978.md) | [(0.04)](/filings/0001437749-26-017162.md) | [(0.04)](/filings/0001437749-26-027732.md) |
| Basic EPS | $ per share | not reported | [(0.06)](/filings/0001437749-25-003789.md) | [(0.06)](/filings/0001437749-25-017251.md) | [(0.03)](/filings/0001437749-25-026998.md) | not reported | [(0.06)](/filings/0001437749-26-003978.md) | [(0.10)](/filings/0001437749-26-017162.md) | [(0.07)](/filings/0001437749-26-027732.md) | not reported | [(0.01)](/filings/0001437749-26-003978.md) | [(0.04)](/filings/0001437749-26-017162.md) | [(0.04)](/filings/0001437749-26-027732.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [2.4](/filings/0001437749-24-038328.md) | [1.4](/filings/0001437749-24-004190.md) | [1.3](/filings/0001437749-24-016714.md) | [1.2](/filings/0001437749-24-026874.md) | [1.4](/filings/0001437749-25-038337.md) | [1.5](/filings/0001437749-25-003789.md) | [2.8](/filings/0001437749-25-017251.md) | [2.1](/filings/0001437749-25-026998.md) | [1.6](/filings/0001437749-26-027732.md) | [1.5](/filings/0001437749-26-003978.md) | [1.4](/filings/0001437749-26-017162.md) | [1.5](/filings/0001437749-26-027732.md) |
| Current assets | $m | [3.7](/filings/0001437749-24-038328.md) | [3.1](/filings/0001437749-24-004190.md) | [3.2](/filings/0001437749-24-016714.md) | [3.1](/filings/0001437749-24-026874.md) | [2.9](/filings/0001437749-25-038337.md) | [3.1](/filings/0001437749-25-003789.md) | [4.7](/filings/0001437749-25-017251.md) | [4.1](/filings/0001437749-25-026998.md) | [3.5](/filings/0001437749-26-027732.md) | [3.7](/filings/0001437749-26-003978.md) | [3.5](/filings/0001437749-26-017162.md) | [3.3](/filings/0001437749-26-027732.md) |
| Total assets | $m | [17.6](/filings/0001437749-24-038328.md) | [16.6](/filings/0001437749-24-004190.md) | [16.3](/filings/0001437749-24-016714.md) | [16.0](/filings/0001437749-24-026874.md) | [15.6](/filings/0001437749-25-038337.md) | [15.5](/filings/0001437749-25-003789.md) | [17.0](/filings/0001437749-25-017251.md) | [16.1](/filings/0001437749-25-026998.md) | [15.3](/filings/0001437749-26-027732.md) | [15.7](/filings/0001437749-26-003978.md) | [15.3](/filings/0001437749-26-017162.md) | [15.3](/filings/0001437749-26-027732.md) |
| Current liabilities | $m | [4.7](/filings/0001437749-24-038328.md) | [4.4](/filings/0001437749-24-004190.md) | [4.6](/filings/0001437749-24-016714.md) | [4.6](/filings/0001437749-24-026874.md) | [4.7](/filings/0001437749-25-038337.md) | [5.1](/filings/0001437749-25-003789.md) | [5.5](/filings/0001437749-25-017251.md) | [5.3](/filings/0001437749-25-026998.md) | [5.0](/filings/0001437749-26-027732.md) | [5.2](/filings/0001437749-26-003978.md) | [5.2](/filings/0001437749-26-017162.md) | [5.3](/filings/0001437749-26-027732.md) |
| Total liabilities | $m | [6.2](/filings/0001437749-24-038328.md) | [5.7](/filings/0001437749-24-004190.md) | [5.8](/filings/0001437749-24-016714.md) | [5.6](/filings/0001437749-24-026874.md) | [5.6](/filings/0001437749-25-038337.md) | [6.0](/filings/0001437749-25-003789.md) | [6.4](/filings/0001437749-25-017251.md) | [6.2](/filings/0001437749-25-026998.md) | [5.8](/filings/0001437749-26-027732.md) | [6.2](/filings/0001437749-26-003978.md) | [6.1](/filings/0001437749-26-017162.md) | [6.4](/filings/0001437749-26-027732.md) |
| Long-term debt | $m | [0.7](/filings/0001437749-24-038328.md) | [0.6](/filings/0001437749-24-004190.md) | [0.6](/filings/0001437749-24-016714.md) | [0.5](/filings/0001437749-24-026874.md) | [0.5](/filings/0001437749-25-038337.md) | [0.4](/filings/0001437749-25-003789.md) | [0.4](/filings/0001437749-25-017251.md) | [0.3](/filings/0001437749-25-026998.md) | [0.2](/filings/0001437749-26-027732.md) | [0.2](/filings/0001437749-26-003978.md) | [0.1](/filings/0001437749-26-017162.md) | [0.1](/filings/0001437749-26-027732.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.2](/filings/0001437749-26-027732.md) | [0.1](/filings/0001437749-26-003978.md) | [0.1](/filings/0001437749-26-017162.md) | [0.1](/filings/0001437749-26-027732.md) |
| Shareholders' equity | $m | [11.5](/filings/0001437749-25-038337.md) | [10.9](/filings/0001437749-25-026998.md) | [10.5](/filings/0001437749-25-026998.md) | [10.3](/filings/0001437749-25-026998.md) | [10.0](/filings/0001437749-26-027732.md) | [9.6](/filings/0001437749-26-027732.md) | [10.6](/filings/0001437749-26-027732.md) | [9.9](/filings/0001437749-26-027732.md) | [9.6](/filings/0001437749-26-027732.md) | [9.6](/filings/0001437749-26-027732.md) | [9.2](/filings/0001437749-26-027732.md) | [8.9](/filings/0001437749-26-027732.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt, us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(72.0) d](/filings/0001437749-24-038328.md) | [(896)](/filings/0001437749-25-003789.md) | [(86.0) d](/filings/0001437749-25-017251.md) | [0.0 d](/filings/0001437749-25-026998.md) | [217 d](/filings/0001437749-25-038337.md) | [178](/filings/0001437749-26-003978.md) | [(372) d](/filings/0001437749-26-017162.md) | [(565) d](/filings/0001437749-26-027732.md) | [(345) d](/filings/0001437749-25-038337.md) | [(39.0)](/filings/0001437749-26-003978.md) | [(40.0) d](/filings/0001437749-26-017162.md) | [155 d](/filings/0001437749-26-027732.md) |
| Capital expenditure | $k | [2.0 d](/filings/0001437749-24-038328.md) | [0.0](/filings/0001437749-25-003789.md) | [5.0 d](/filings/0001437749-25-017251.md) | [19.0 d](/filings/0001437749-25-026998.md) | [5.0 d](/filings/0001437749-25-038337.md) | [5.0](/filings/0001437749-26-003978.md) | [2.0 d](/filings/0001437749-26-017162.md) | [5.0 d](/filings/0001437749-26-027732.md) | [6.0 d](/filings/0001437749-25-038337.md) | [7.0](/filings/0001437749-26-003978.md) | [17.0 d](/filings/0001437749-26-017162.md) | [16.0 d](/filings/0001437749-26-027732.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q1 FY2023 (2022-12-31) | Q2 FY2023 (2023-03-31) | Q3 FY2023 (2023-06-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [10.4](/filings/0001437749-24-004190.md) | [10.4](/filings/0001437749-24-016714.md) | [10.4](/filings/0001437749-24-026874.md) | [10.4](/filings/0001437749-25-003789.md) | [10.4](/filings/0001437749-25-017251.md) | [10.4](/filings/0001437749-25-026998.md) | [10.4](/filings/0001437749-26-003978.md) | [10.5](/filings/0001437749-26-017162.md) | [11.9](/filings/0001437749-26-027732.md) | [12.0](/filings/0001437749-26-003978.md) | [12.1](/filings/0001437749-26-017162.md) | [12.1](/filings/0001437749-26-027732.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 12,599,879 at 2026-08-13, from the cover of the [10-Q filed 2026-08-13](/filings/0001437749-26-027732.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:38 ET. No prices; not investment advice.